[ad_1] Insilico Medicine, a Hong Kong-based AI-driven drug discovery company that intends to list in Hong Kong after it unveiled an initial public offering plan (IPO) last year, has sold…
Tag: Insilico
Trenchant Announces Strategic Investment in GNQ Insilico Inc.
[ad_1] Vancouver, British Columbia–(Newsfile Corp. – December 1, 2023) – Trenchant Capital Corp. (CSE: TCC) (the “Company“) is pleased to announce that it has entered into a strategic investment with…